SUPPRESSION OF DIALYSIS PATIENTS' LYMPHOCYTE IL-2R EXPRESSION BY GLUCOCORTICOIDS AND CYCLOSPORINE
William A. Briggs, James F. Burdick(University of Baltimore), Paul J. Scheel(University of Minnesota), Michael Choi(Rush University Medical Center), Milagros Samaniego(Henry Ford Health System), Jing-Jing Xing(Johns Hopkins University), Luis F. Gimenez(Johns Hopkins University), Zu‐Hua Gao(BC Cancer Agency)
Cited by 8
Related Papers
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
|Kidney International|2013|350
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
|American Journal of Kidney Diseases|2013|239